Correlation Between Black Diamond and Voyager Therapeutics

Can any of the company-specific risk be diversified away by investing in both Black Diamond and Voyager Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Black Diamond and Voyager Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Black Diamond Therapeutics and Voyager Therapeutics, you can compare the effects of market volatilities on Black Diamond and Voyager Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Black Diamond with a short position of Voyager Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Black Diamond and Voyager Therapeutics.

Diversification Opportunities for Black Diamond and Voyager Therapeutics

-0.09

Correlation Coefficient

Black Diamond  Voyager Therapeutics

Good diversification

The 3 months correlation between Black and Voyager is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Black Diamond Therapeutics and Voyager Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Voyager Therapeutics and Black Diamond is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Black Diamond Therapeutics are associated (or correlated) with Voyager Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Voyager Therapeutics has no effect on the direction of Black Diamond i.e., Black Diamond and Voyager Therapeutics go up and down completely randomly.

Pair Corralation between Black Diamond and Voyager Therapeutics

Given the investment horizon of 90 days Black Diamond Therapeutics is expected to generate 0.9 times more return on investment than Voyager Therapeutics. However, Black Diamond Therapeutics is 1.12 times less risky than Voyager Therapeutics. It trades about 0.23 of its potential returns per unit of risk. Voyager Therapeutics is currently generating about 0.02 per unit of risk. If you would invest  155.00  in Black Diamond Therapeutics on May 7, 2025 and sell it today you would earn a total of  118.00  from holding Black Diamond Therapeutics or generate 76.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Black Diamond Therapeutics  vs.  Voyager Therapeutics

Black Diamond Therap

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Black Diamond Therapeutics are ranked lower than 17 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Black Diamond showed solid returns over the last few months and may actually be approaching a breakup point.

Voyager Therapeutics

Risk-Adjusted Performance

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Voyager Therapeutics are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively invariable technical and fundamental indicators, Voyager Therapeutics is not utilizing all of its potentials. The recent stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Black Diamond and Voyager Therapeutics

The main advantage of trading using opposite Black Diamond and Voyager Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Black Diamond position performs unexpectedly, Voyager Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Voyager Therapeutics will offset losses from the drop in Voyager Therapeutics' long position.

The idea behind Black Diamond Therapeutics and Voyager Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..